Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells

Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling

(2017) Ke Jiang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Epithelial-to-mesenchymal transition in tumor progression

(2017) Elena Prieto-García et al.   MEDICAL ONCOLOGY

Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway

(2017) Cheng-Dong Qin et al.   ONCOLOGY REPORTS

3-Phosphoinositide Dependent Protein Kinase-1 (PDK-1) Promotes Migration and Invasion in Gastric Cancer Cells Through Activating the NF-κB Pathway

(2017) Ning Wu et al.   ONCOLOGY RESEARCH

Recent progress on the effects of microRNAs and natural products on tumor epithelial–mesenchymal transition

(2017) Shujin He et al.   OncoTargets and Therapy

Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement

(2016) Simona Dinicola et al.   EXPERIMENTAL CELL RESEARCH

Research review on the pharmacological effects of astragaloside IV

(2016) Lei Li et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients

(2015) Sitai Liang et al.   Oncotarget

Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention

(2014) P. Karimi et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Astragaloside IV Inhibits Doxorubicin-Induced Cardiomyocyte Apoptosis Mediated by Mitochondrial Apoptotic Pathway via Activating the PI3K/Akt Pathway

(2014) Yuanyuan Jia et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway

(2014) Xudong Cheng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO

(2014) Anle Zhang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells

(2012) Z Liu et al.   ONCOGENE

The Ins and Outs of the Epithelial to Mesenchymal Transition in Health and Disease

(2011) M. Angela Nieto   Annual Review of Cell and Developmental Biology

Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition

(2011) Chun-Yu Lin et al.   CANCER SCIENCE

EMT: New signals from the invasive front

(2011) Xinhua Liang   ORAL ONCOLOGY

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION